Stimcell Energetics Inc. (STME) — SEC Filings
Stimcell Energetics Inc. (STME) — 16 SEC filings. Latest: 8-K (Dec 2, 2025). Includes 8 8-K, 6 10-Q, 2 10-K.
View Stimcell Energetics Inc. on SEC EDGAR
Overview
Stimcell Energetics Inc. (STME) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 8-K filed on Dec 2, 2025: Stimcell Energetics Inc. filed an 8-K on December 2, 2025, reporting under Regulation FD and including financial statements and exhibits. The company, formerly known as Cell MedX Corp., is incorporated in Nevada and based in Vancouver, British Columbia.
Sentiment Summary
Across 16 filings, the sentiment breakdown is: 1 bearish, 14 neutral, 1 mixed. The dominant filing sentiment for Stimcell Energetics Inc. is neutral.
Filing Type Overview
Stimcell Energetics Inc. (STME) has filed 8 8-K, 6 10-Q, 2 10-K with the SEC between Jan 2024 to Dec 2025.
Filings by Year
Recent SEC Filings (16)
Risk Profile
Risk Assessment: Of STME's 16 recent filings, 2 were flagged as high-risk, 7 as medium-risk, and 7 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.
Financial Highlights
| Metric | Value |
|---|---|
| Net Income | -$265,602 |
| Cash Position | $6,437 |
| Total Assets | $16,387 |
| Total Debt | $1,410,336 |
Key Executives
- Richard Jeffs
- David Jeffs
- Amir Vahabzadeh
- Dr. Richard Tytus
Industry Context
Stimcell Energetics Inc. operates in the biotech and wellness sector, focusing on therapeutic and non-therapeutic products related to general health, anti-aging, and pain relief. The company's subsidiary, Cell MedX (Canada), is developing devices based on proprietary eBalance Technology using microcurrents. This market is competitive, with numerous companies vying for innovation in areas like diabetes management, neuropathy, and wellness devices.
Top Tags
10-Q (5) · financials (4) · 8-K (3) · equity-sale (3) · Biotech (2) · material-agreement (2) · disclosure (2) · corporate-governance (2) · filing (2) · SEC Filing (2)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| SEC File Number | 000-54500 | Identifies the company's filing with the SEC. |
| IRS Employer Identification No. | 38-3939625 | Company's tax identification number. |
| Net Loss | $265,602 | Increased by 296.9% from $66,919 in the prior year quarter |
| Cash on Hand | $6,437 | Decreased from $14,581 at May 31, 2025 |
| Total Liabilities | $1,410,336 | Increased from $1,267,508 at May 31, 2025 |
| Notes and Advances Due to Related Parties | $582,013 | Increased from $469,874 at May 31, 2025 |
| Accumulated Deficit | $11,127,158 | Increased from $10,861,556 at May 31, 2025 |
| General and Administrative Expenses | $139,484 | Increased from $16,451 in the prior year quarter |
| Research and Development Costs | $57,309 | Incurred for eBalance microcurrent device redesign, up from $0 in prior year |
| Common Shares Outstanding | 20,641,272 | As of October 14, 2025 |
| Value of Shares Issued for Services | $120,000 | 375,000 shares issued for investor relations |
| Total Borrowed from Richard Jeffs | $150,000 | Including $100,000 during the quarter and $50,000 subsequently |
| Aggregate Market Value of Non-Affiliate Common Equity | $5,909,613 | As of November 30, 2024, reflecting the company's market capitalization. |
| Reverse Stock Split Ratio | 1-for-15 | Completed on November 1, 2024, significantly reducing outstanding shares. |
| Adults Living with Diabetes Worldwide | 537 million | In 2021, according to IDF, highlighting the large target market for eBalance Technology. |
Frequently Asked Questions
What are the latest SEC filings for Stimcell Energetics Inc. (STME)?
Stimcell Energetics Inc. has 16 recent SEC filings from Jan 2024 to Dec 2025, including 8 8-K, 6 10-Q, 2 10-K. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of STME filings?
Across 16 filings, the sentiment breakdown is: 1 bearish, 14 neutral, 1 mixed. The dominant sentiment is neutral.
Where can I find Stimcell Energetics Inc. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Stimcell Energetics Inc. (STME) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Stimcell Energetics Inc.?
Key financial highlights from Stimcell Energetics Inc.'s most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for STME?
The investment thesis for STME includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Stimcell Energetics Inc.?
Key executives identified across Stimcell Energetics Inc.'s filings include Richard Jeffs, David Jeffs, Amir Vahabzadeh, Dr. Richard Tytus.
What are the main risk factors for Stimcell Energetics Inc. stock?
Of STME's 16 assessed filings, 2 were flagged high-risk, 7 medium-risk, and 7 low-risk.
What are recent predictions and forward guidance from Stimcell Energetics Inc.?
Forward guidance and predictions for Stimcell Energetics Inc. are extracted from SEC filings as they are enriched.